BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18313528)

  • 1. Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
    Busk M; Horsman MR; Jakobsen S; Keiding S; van der Kogel AJ; Bussink J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1202-12. PubMed ID: 18313528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.
    Busk M; Munk OL; Jakobsen S; Wang T; Skals M; Steiniche T; Horsman MR; Overgaard J
    Acta Oncol; 2010 Oct; 49(7):922-33. PubMed ID: 20831479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
    Busk M; Horsman MR; Jakobsen S; Hansen KV; Bussink J; van der Kogel A; Overgaard J
    Radiother Oncol; 2009 Sep; 92(3):429-36. PubMed ID: 19729214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
    Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
    J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
    Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
    Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
    O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant impact of different oxygen breathing conditions on noninvasive in vivo tumor-hypoxia imaging using [¹⁸F]-fluoro-azomycinarabino-furanoside ([¹⁸F]FAZA).
    Maier FC; Kneilling M; Reischl G; Cay F; Bukala D; Schmid A; Judenhofer MS; Röcken M; Machulla HJ; Pichler BJ
    Radiat Oncol; 2011 Nov; 6():165. PubMed ID: 22118419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
    Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
    Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
    Picchio M; Beck R; Haubner R; Seidl S; Machulla HJ; Johnson TD; Wester HJ; Reischl G; Schwaiger M; Piert M
    J Nucl Med; 2008 Apr; 49(4):597-605. PubMed ID: 18344437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
    Beck R; Röper B; Carlsen JM; Huisman MC; Lebschi JA; Andratschke N; Picchio M; Souvatzoglou M; Machulla HJ; Piert M
    J Nucl Med; 2007 Jun; 48(6):973-80. PubMed ID: 17536108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.
    Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA
    J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
    Sørensen M; Horsman MR; Cumming P; Munk OL; Keiding S
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):854-61. PubMed ID: 15936570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET hypoxia imaging with FAZA: reproducibility at baseline and during fractionated radiotherapy in tumour-bearing mice.
    Busk M; Mortensen LS; Nordsmark M; Overgaard J; Jakobsen S; Hansen KV; Theil J; Kallehauge JF; D'Andrea FP; Steiniche T; Horsman MR
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):186-97. PubMed ID: 23076620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
    Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
    J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results.
    Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ
    J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging.
    Solomon B; Binns D; Roselt P; Weibe LI; McArthur GA; Cullinane C; Hicks RJ
    Mol Cancer Ther; 2005 Sep; 4(9):1417-22. PubMed ID: 16170034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia imaging with FAZA-PET and theoretical considerations with regard to dose painting for individualization of radiotherapy in patients with head and neck cancer.
    Grosu AL; Souvatzoglou M; Röper B; Dobritz M; Wiedenmann N; Jacob V; Wester HJ; Reischl G; Machulla HJ; Schwaiger M; Molls M; Piert M
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):541-51. PubMed ID: 17869667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
    Yaromina A; Quennet V; Zips D; Meyer S; Shakirin G; Walenta S; Mueller-Klieser W; Baumann M
    Int J Radiat Biol; 2009 Nov; 85(11):972-80. PubMed ID: 19895274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity.
    Busk M; Munk OL; Jakobsen SS; Horsman MR
    Acta Oncol; 2017 Nov; 56(11):1583-1590. PubMed ID: 28840765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
    Mortensen LS; Busk M; Nordsmark M; Jakobsen S; Theil J; Overgaard J; Horsman MR
    Radiother Oncol; 2011 Jun; 99(3):418-23. PubMed ID: 21723634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.